Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
2.010
+0.140 (7.49%)
Oct 20, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $119.36 million as of October 20, 2026. It is the 24,020th most valuable company in the world and the 3,961st biggest in the United States. Its market cap has decreased by 47.08% in one year.
Market Cap
119.36M
Enterprise Value
-5.12M
1-Year Change
-47.08%
Global Rank
Country Rank
#3,961 United States
Category
ChartMarket Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $119.36M, a decrease of -78.89%. That is a compound annual growth rate of -22.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 119.36M | -60.91% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 126.59M |
| Anavex Life Sciences | 126.07M |
| Nkarta | 124.63M |
| Cue Biopharma | 123.79M |
| Minerva Neurosciences | 120.80M |
| Armata Pharmaceuticals | 118.98M |
| Black Diamond Therapeutics | 118.93M |
| Spruce Biosciences | 116.11M |